XOLTAR
AI-powered Patient Engagement and Adherence Platform
Company Overview
Snapshot
Founded in July 2020 by Asaf Shiloni and Tal Meller, XOLTAR operates with 11–50 employees. The company has secured funding across one round from 97212 Ventures. In August 2023, XOLTAR received Pre-Seed funding from 97212 Ventures.
Business overview
XOLTAR develops an AI-powered patient engagement and adherence platform within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Engagement. The company's core technology leverages generative AI to provide real-time, 24/7 interaction with AI-based accountability partners. This platform can interpret nonverbal cues and remember past sessions, offering guided video conversations that emulate relationship care. XOLTAR serves healthcare providers, pharma companies, and clinics, addressing various use cases including patient support companions for chronic conditions like oncology and diabetes.
Strategic signal
In March 2025, XOLTAR's AI-powered patient engagement platform was highlighted in discussions regarding the role of AI nurses in hospital staffing solutions. This signals a growing industry recognition of AI's potential to address healthcare workforce challenges and improve patient care quality, positioning XOLTAR as a relevant player in the evolving landscape of AI-driven healthcare delivery.
Log in to access full profile ›Company Intelligence Q&A
- What is XOLTAR's primary focus?
- XOLTAR focuses on AI-powered patient engagement and adherence, utilizing generative AI to create interactive accountability partners for patients.
- When was XOLTAR founded and by whom?
- XOLTAR was founded in July 2020 by Asaf Shiloni and Tal Meller.
- Which investor participated in XOLTAR's Pre-Seed funding round?
- In August 2023, XOLTAR received Pre-Seed funding from 97212 Ventures, which was the sole disclosed investor in this round.
- What markets does XOLTAR target?
- XOLTAR targets geomarkets including Israel, North America, and Europe, serving healthcare providers, pharma companies, and clinics.
- What was a significant news mention for XOLTAR in March 2025?
- In March 2025, XOLTAR was mentioned in an article discussing the role of AI nurses as a staffing solution for hospitals, highlighting the company's relevance in the application of AI in healthcare.